The Breakthrough: Immunotherapy and the Race to Cure Cancer
One hundred years ago, physicians marvelled at patients with bacterial infections who appeared to have been spontaneously cured of deadly tumours. What was a miraculous mystery then is now hard scientific fact- immunotherapy is the cutting edge of cancer treatment, and a crucial ... read full description below.
Usually ships 6-12 working days – This title is in stock at publisher
||8 January 2019 by Scribe Publications
||By Graeber, Charles
||In stock at publisher; ships 6-12 working days
... view full title details below.
- $37.00 Retail price
- $28.86 Wheelers price
- You save $8.14!
Full details for this title
Description of this Book
One hundred years ago, physicians marvelled at patients with bacterial infections who appeared to have been spontaneously cured of deadly tumours. What was a miraculous mystery then is now hard scientific fact- immunotherapy is the cutting edge of cancer treatment, and a crucial breakthrough in the race to find the ultimate cure.Journalist Charles Graeber expertly traces the fascinating history of immuno-oncology and guides readers through the revolutionary scientific research bringing cancer treatment into the 21st century. As advances in our understanding of cancer and the human immune system continue to fuel a therapeutic arms race among biotech and pharmaceutical companies around the world, the next step - harnessing the wealth of new information into modern and more effective patient therapies - is already well underway.The Breakthrough is the first book to address the groundbreaking science of cancer treatment through immunotherapy. It is the incredible true story of the race to find a cure, a dispatch from the life-changing world of oncological science, and a brave new chapter in our fight with cancer.
Awards, Reviews & Star Ratings
||`Only Graeber, one of America's greatest non-fiction writers, could take a subject so complex, dense and sprawling and turn it into a rollicking high-tension medical thriller. Masterful.' -Douglas Rogers, award-winning journalist and author of The Last Resort `A gripping chronicle of the 100-year overnight success of immunotherapy. For myself and millions of other cancer survivors, The Breakthrough is a book of immense and essential hope.' -Michael Fitzgerald, co-founder and CEO of Submittable and author of Radiant Days `There is no villain more ruthless than cancer, which has robbed us all of loved ones who had to endure untold suffering before they succumbed. But after decades of frustration and toil, scientists finally understand how to vanquish the disease by activating the human body's natural defences. The intimate stories behind this triumph lie at the heart of Charles Graeber's The Breakthrough, an expertly crafted and exhilarating account of life-saving ingenuity at its most dazzling. You will never encounter another book so incisive about the art of medical sleuthing, or so poetic about our innate drive to hold on to all that's beautiful in this world for as long as we can.' -Brendan I. Koerner, Wired contributing editor and author of The Skies Belong to Us `Lucid and informed ... Graeber gives readers a basis for both understanding the challenges involved and for cautious optimism that a cure can be found.' -Publishers Weekly `Graeber concisely reviews the science of cancer ... The risks of tinkering with an intricate immune system are obviously high, even perilous. But the potential reward is a cure. Exciting reading.' -Booklist `Imagine a vaccine that could cure cancer. As this book reports, that possibility may not be far off ... [T]he book offers hope for more effective treatments in the near future. A readable survey of the emerging field of immunotherapy in cancer treatment.' -Kirkus `In Mr Graeber's hands, the evolution of immuno-oncology is both captivating and heartbreaking.' -David A. Shaywitz, The Wall Street Journal
Charles Graeber is a contributing editor for Wired and a contributor to publications such as The New York Times, The New Yorker, GQ, Vogue, and many others. He has received many awards, and his work has been featured on NPR, CNN, the BBC, and numerous other media outlets.